Palantir Technologies Inc.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Net income ($1.2b)
($520.4m) +55.39%
($371.1m) +28.69%
$217.4m +158.58%
$467.9m +115.26%
$1.6b +249.34%
$3.0b +85.41%
Depreciation and amortization $13.9m $12.3m $13.9m $14.9m $22.5m $33.4m $31.6m $26.1m $28.0m
Stock-based compensation $248.5m $242.0m $1.3b $778.2m $564.8m $475.9m $691.6m $684.0m $835.5m
Accounts receivable, net ($10.5m) ($23.9m) ($108.5m) ($35.2m) ($77.5m) ($106.2m) ($211.2m) ($450.4m) ($720.7m)
Accounts payable and accrued liabilities $21.1m $96.8m $4.7m $44.6m
Accrued taxes related to net share settlement of equity awards $0 $0 $84.2m $0
Other operating activities $420k $2.8m $4.4m $2.7m $6.7m ($29.4m) $24.8m $15.6m
Prepaid expenses and other assets ($19.4m) $18.8m ($18.6m) ($10.9m) ($26.0m) ($6.2m) $7.2m $52.0m
Other liabilities ($49.6m) ($44.4m) ($54.9m)
Net cash provided by operating activities ($39.0m)
($165.2m) -323.50%
($296.6m) -79.53%
$333.9m +212.56%
$223.7m -32.98%
$712.2m +218.31%
$1.2b +62.02%
$2.1b +84.98%
$3.4b +59.30%
Purchases of property and equipment ($13.0m) ($13.1m) ($12.2m) ($12.6m) ($40.0m) ($15.1m) ($12.6m) ($33.9m) ($42.0m)
Unrealized and realized (gain) loss from marketable securities, net $0 $0 $73.3m $272.1m $13.2m $19.3m $21.2m
Purchases of marketable securities $0 $0 ($308.3m) ($124.5m) ($5.6b) ($5.4b) ($7.7b)
Proceeds from sales and redemption of marketable securities $0 $851k $52.3m $2.9b $5.1b $5.0b
Other investing activities $0 $250k ($3.0m) $73k $0 ($5.6m) ($1.0m)
Net cash used in investing activities ($6.8m) ($22.0m) ($14.9m) ($397.9m) ($45.4m) ($2.7b) ($340.7m) ($2.8b) ($2.3b)
Proceeds from the exercise of common stock options $12.7m $16.9m $298.8m $0 $86.1m $218.2m $745.4m $129.1m
Repurchases of common stock ($7.7m) ($11.2m) ($3.8m) $0 $0 $0 ($64.2m) $75.0m
Taxes paid related to net share settlement of equity awards $17.1m $8.6m $14.3m $4.1m $0 $0 ($218.3m) ($81.1m)
Other financing activities $1.2m ($1.2m) ($497k) ($708k) ($93k) $601k $444k $85k
Net cash provided by (used in) financing activities $46.2m
$324.5m +603.15%
$1.0b +219.37%
$306.7m -70.40%
$86.0m -71.97%
$218.8m +154.48%
$463.4m +111.74%
($668.5m) -244.27%
$3.9m +100.59%
Cash, cash equivalents, and restricted cash - beginning of period $1.3b $1.4b $2.1b $2.4b $2.6b $850.1m $2.1b $1.5b
Effect of foreign exchange on cash, cash equivalents, and restricted cash ($3.7m) ($2.2m) $1.3m ($3.9m) ($3.9m) $2.9m ($6.7m) $7.5m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Noncash consideration $0 ($15.5m) ($46.6m) ($52.5m) ($37.2m)
Contract liabilities $126.0m $279.2m ($230.9m) ($104.9m) ($49.5m) $64.3m $54.4m $238.7m
Purchases of privately-held securities $0 $0 ($23.0m) $0 $0 ($5.6m) ($72.9m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.